ClassID:

93253

C07C279/22 - CPC Classification

Classification description:

Derivatives of guanidine, i.e. compounds containing the group , the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups , X being a hetero atom, Y being any atom, e.g. acylguanidines Y being a hydrogen or a carbon atom, e.g. benzoylguanidines

Recent Application in this class:
#1
20240360075
2024-10-31

N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF

#2
20240092731
2024-03-21

CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF

#3
20220298268
2022-09-22

Photobase generator, compound, photoreactive composition, and reaction product

#4
20220227703
2022-07-21

Creatine prodrugs, compositions and methods of use thereof

#5
20210155597
2021-05-27

COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN

#6
20210053958
2021-02-25

Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof

#7
20210002211
2021-01-07

Creatine prodrugs, compositions and methods of use thereof

#8
20200385340
2020-12-10

HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS

#9
20200281909
2020-09-10

Ethynyl compounds, their preparation and their therapeutic use for the treatment of malaria

#10
20190389816
2019-12-26

Antiviral compounds and methods

#11
20190330157
2019-10-31

Therapeutic compounds

#12
20190225599
2019-07-25

Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof

#13
20180141937
2018-05-24

Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof

#14
20170362170
2017-12-21

HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS

#15
20170342025
2017-11-30

ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS

#16
20170260147
2017-09-14

Antiviral compounds and methods

#17
20170037039
2017-02-09

Retinoic acid receptor antagonists as chaperone-mediated authophagy modulators and uses thereof

#18
20160376231
2016-12-29

Antiviral compounds and methods

#19
20160289175
2016-10-06

CREATINE ANALOGS AND THE USE THEREOF

#20
20150361037
2015-12-17

Acylguanidines for treating osteoarthritis

#21
20150313909
2015-11-05

ANTIVIRAL COMPOUNDS AND METHODS

#22
20150307446
2015-10-29

Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis

#23
20150166492
2015-06-18

Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof

#24
20150158832
2015-06-11

Compounds and methods of treating cancer

#25
20150023921
2015-01-22

HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS

#26
20140371232
2014-12-18

Cajanine structure analogous compound, preparation method and use

#27
20140228441
2014-08-14

Compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications

#28
20140066487
2014-03-06

Antiviral compounds and methods

#29
20130331392
2013-12-12

Cycloalkyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#30
20130210904
2013-08-15

Synthesis of bicyclic compounds and method for their use as therapeutic agents

#31
20130035328
2013-02-07

ANTIVIRAL COMPOUNDS AND METHODS

#32
20120196865
2012-08-02

Acyl guanidine derivatives modulating the hedgehog protein signaling pathway

#33
20120190880
2012-07-26

Methods and compositions for preparation of amphetamine conjugates and salts thereof

#34
20120178666
2012-07-12

PRODRUGS OF GUANFACINE

#35
20120093728
2012-04-19

Mitochondrial inhibitors to treat human disease

#36
20120088737
2012-04-12

NOVEL ACYL GUANIDINE DERIVATIVES

#37
20120041036
2012-02-16

SUBSTITUTED ACYLGUANIDINE DERIVATIVES (AS AMENDED)

#38
20110306621
2011-12-15

ACYLGUANIDINE DERIVATIVES

#39
20110207729
2011-08-25

BICYCLIC ACYLGUANIDINE DERIVATIVE

#40
20110160225
2011-06-30

COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS

#41
20110082109
2011-04-07

NOVEL ACYL GUANIDINE DERIVATIVES

#42
20110065796
2011-03-17

PRODRUGS OF GUANFACINE

#43
20100254942
2010-10-07

HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS

#44
20100222400
2010-09-02

FF-ATPase inhibitors and related methods

#45
20100041665
2010-02-18

N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

#46
20090203696
2009-08-13

Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics

#47
20090198056
2009-08-06

β secretase inhibitor

#48
20090099239
2009-04-16

Antiviral compounds and methods

#49
20090054450
2009-02-26

COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS

#50
20080300420
2008-12-04

Process for the Preparation of Entacapone Form-A

#51
20080200705
2008-08-21

Creatine-fatty acids

#52
20080200704
2008-08-21

PREPARATION OF AMINO ACID-FATTY ACID AMIDES

#53
20080200551
2008-08-21

Flourene Derivative

#54
20080021055
2008-01-24

Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists

#55
20070293498
2007-12-20

Modulators of melanocortin receptor

#56
20070281996
2007-12-06

Creatine prodrugs, compositions and uses thereof

#57
20070281995
2007-12-06

Creatine analog prodrugs, compositions and uses thereof

#58
20070275436
2007-11-29

Polyene polyketides, processes for their production and their use as a pharmaceutical

#59
20070232581
2007-10-04

Oxime-containing acyl guanidines as beta-secretase inhibitors

#60
20070088015
2007-04-19

Non-nucleoside reverse transcriptase inhibitors

#61
20060183943
2006-08-17

Terphenyl guanidines as β-secretase inhibitors

#62
20050187167
2005-08-25

Polyene polyketides, processes for their production and their use as a pharmaceutical

#63
20050004185
2005-01-06

Polyene polyketides, processes for their production and their use as pharmaceuticals